Heidi has established its regional hub in Singapore following a US$65 million Series B funding round led by Point72 Private Investments. The Singapore office will act as the regional headquarters in Southeast Asia.
The healthcare AI company plans to invest up to US$8 million over the next two to three years to build local teams in sales, implementation and clinical partnerships, and aims to hire 10 to 12 roles initially with potential for further expansion.
This strategic move comes as Singapore faces healthcare system pressures due to an aging population and a growing shortage of clinicians. By 2030, one in four Singaporeans will be aged 65 or older, with only one doctor per 343 residents, intensifying healthcare challenges.
Heidi’s AI platform automates clinical documentation by transcribing doctor-patient conversations into structured notes, increasing clinician capacity to focus more on patient care. About 55,000 consultations in Singapore have already been supported by the platform. Its customers in Singapore include the Osler Group.
“For Heidi, Singapore represents more than a market entry, it’s a launchpad for the next phase of healthcare innovation and growth across Southeast Asia. Backed by a supportive ecosystem, deep talent pool and initiatives such as the Trust platform that enables secure, privacy-conscious data sharing, Singapore is uniquely positioned to accelerate responsible AI adoption in healthcare,” said Thomas Kelly, CEO and Co-founder of Heidi.
Entelechy Asia 